Will Cannabis Genetics Be Restricted?

The redefinition of hemp under federal law, scheduled to take effect Nov. 12, signals the loss of Farm Bill safeguards for numerous hemp-derived THC items across the country: mild beverages as well as THCA bud and delta-8 THC edibles, vapes and additional products available at gas stops and smoke shops.

But the hemp prohibition also creates a significant complication for the legitimate cannabis industry. Seeds from cannabis cultivars that produce flower with greater than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will probably continue in authorized states, the modifications threaten to close some seed banks and genetics businesses, observers note, while creating supply-chain problems for cannabis growers and retailers.

"If this wording goes forward, we will require pop-up shops to offer seeds in each state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue culture, because that's not covered in the bill."

When are cannabis genetics and clones prohibited to ship between state lines?

The updated regulations classify seeds depending on the THC capacity of the parent plant. Genetic material such as seeds and clones are rendered illegal if the final product crosses the threshold.

For the moment, nativesusa.com, seeds are still shipping under the 2018 Farm Bill's status quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain interruptions if out-of-state access to genetics is prohibited.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, co-founder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the way of an exception for seeds or an overall moratorium, numerous seed providers will simply be shuttered come November, he added.

"We are operating legally currently, but if that changes, it will disrupt the legal licensed industry in every state," said Power, whose customers includes seed banks as well as licensed business cultivators.

"Customers are going to lose choice, and it will be a major shutdown for many people."

What are cannabis seed banks doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which strengthened cannabis oversight in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Formerly a seed bank, Silberhaze is now focused on the branding, preservation and IP protection of premium plant genetics.

That's because seed businesses hoping to remain compliant in this new environment must have solid documentation, he said.

"You have to demonstrate where this material comes from, so it's extremely important to have documentation, even to the point where you have breeder names," Silber said.

"Small businesses will have to operate with improved records and a better chain of custody," he added. "We want that documentation too, because we don't want to be working with questionable sources."

To avoid seizures and additional legal consequences, seed entrepreneurs must "get their affairs in order" before the updated regulations take place, Silber said.

"Audit all your stuff immediately, and classify what you can," Silber said. "Take inventory, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene data you already have. If regulations change, you'll be in a far better position to understand what may be affected and make educated decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.

But for the time being, seed companies can't register with the DEA like state-licensed therapeutic cannabis businesses can. Such a pathway is unavailable to seed banks, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis law group in Cleveland.

"Genetics activity may be occurring inside larger state-licensed medical marijuana businesses, as some states allow dispensaries or registered medical operators to offer seeds, clones or personal growing materials," he said.

"But that is different from the DEA establishing a freestanding seed bank registration category."

Some genetics companies are already changing business practices to conform with the new law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our inventory look like once we organize it against the genetics exclusion?

Ickes also understands confusion from clients who believed federal rescheduling of therapeutic marijuana would resolve their story with financial institutions. However, the latest regulatory wording has shifted those conversations past the basics of classification, he said.

"Banks ask whether this specific revenue source is lawful, whether it connects to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed supplier selling high-THC genetics can't answer the initial question with the hemp definition. It has to point to a legal state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed keep the simpler story."

What's the outlook of cannabis genetics?

Campanella is a member of a emerging coalition of fellow breeders, farmers and researchers that's saying seeds are more appropriately defined as agricultural inputs than controlled substances. To that effect, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement efforts elsewhere.

"How do you regulate something based on what it could become one day?" said Campanella. "Our preference is to have that wording removed, or get seeds regulated by the USDA as a hemp product."

But in the interim, Campanella is restructuring Brothers Grimm to operate outside the scope of shifting federal oversight. The business plans to maintain its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a hedge against federal prohibition of cannabis seeds.

As she noted: "If things evolve in a way where we can't focus on interstate transport, we'll have other resources to satisfy people's needs without getting ourselves in trouble."